Andrew Fine - Net Worth and Insider Trading
Andrew Fine Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew Fine owns 1 companies in total, including Chemomab Therapeutics Ltd (CMMB) .
Click here to see the complete history of Andrew Fine’s form 4 insider trades.
Insider Ownership Summary of Andrew Fine
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CMMB | Chemomab Therapeutics Ltd | 2020-10-20 | Chief Financial Officer |
Andrew Fine Trading Performance
Andrew Fine Ownership Network
Andrew Fine Owned Company Details
What does Chemomab Therapeutics Ltd do?
Who are the key executives at Chemomab Therapeutics Ltd?
Andrew Fine is the Chief Financial Officer of Chemomab Therapeutics Ltd. Other key executives at Chemomab Therapeutics Ltd include 10 percent owner Orbimed Israel Biofund Gp Limited Partnership , director & 10 percent owner & Chief Executive Officer George Adi Mor , and Chief Medical Officer Matthew Bejosa Frankel .
Chemomab Therapeutics Ltd (CMMB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Chemomab Therapeutics Ltd (CMMB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Chemomab Therapeutics Ltd (CMMB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Chemomab Therapeutics Ltd (CMMB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Chemomab Therapeutics Ltd Insider Transactions
Andrew Fine Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew Fine. You might contact Andrew Fine via mailing address: C/o Anchiano Therapeutics Ltd., One Kendall Sq., Bldg 1400e, Ste 14-105, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
